Director dealings: Haleon CFO holds onto vested shares
By Iain Gilbert
Date: Friday 04 Jul 2025
(Sharecast News) - Haleon revealed on Wednesday that chief financial officer Dawn Allen had been awarded 178,012 ordinary shares in the London-listed consumer healthcare company as part of its share value plan and its performance share plan.
Allen then disposed of 83,894 ordinary shares at an average price of 375.64p each, for a total value of £315,137.75, in order to cover tax liabilities arising from the vesting of the award.
As of 1540 BST, Haleon shares were down 0.53% at 373.60p.
Reporting by Iain Gilbert at Sharecast.com
Top Director Buys
Faron Pharmaceuticals Oy (di) (FARN)
Director name: Pätsi,Tuomo
Amount purchased: 21,500 @ 2.43
Value: 47,164.41
Triad Group (TRD)
Director name: Lander,Alison
Amount purchased: 6,722 @ 297.50p
Value: £19,997.95
Utilico Emerging Markets Ltd (di) (UEM)
Director name: Wells ,Nadya
Amount purchased: 3,290 @ 244.00p
Value: £8,027.60
Stelrad Group (SRAD)
Director name: Ker,Katherine Innes
Amount purchased: 2,515 @ 163.00p
Value: £4,099.45
Top Director Sells
Haleon (HLN)
Director name: Allen,Dawn
Amount sold: 64,329 @ 375.64p
Value: £241,644.17
Haleon (HLN)
Director name: Allen,Dawn
Amount sold: 19,565 @ 375.64p
Value: £73,493.58
Rs Group (RS1)
Director name: Ringrose ,Kate
Amount sold: 6,143 @ 580.50p
Value: £35,660.11
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN